Biote Corp. (BTMD)
NASDAQ · Healthcare
Biote Corp. Income Statement 2021–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenue | 192.2M | 197.2M | 185.4M | 165.0M | 139.4M |
| Gross Profit | — | — | — | — | — |
| Profitability | |||||
| Operating Income | 35.6M | 31.6M | 28.7M | -60.7M | 34.6M |
| EBITDA | 39.2M | 35.2M | 31.7M | -58.5M | 36.0M |
| Net Income | 27.0M | 3.2M | 3.3M | -969,000 | 11.1M |
| Per Share Data | |||||
| EPS (diluted) | — | — | — | — | — |
| Shares Outstanding (dil.) | 37M | 34M | 26M | 8M | — |
Biote Corp. Income Statement — FAQ
Biote Corp. (BTMD) income statement over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BTMD's income statement history?
The chart and table above show Biote Corp.'s income statement by year and by quarter, including the growth rate.